These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37534091)

  • 21. GPRC5A Is a Negative Regulator of the Pro-Survival PI3K/Akt Signaling Pathway in Triple-Negative Breast Cancer.
    Yang L; Zhao S; Zhu T; Zhang J
    Front Oncol; 2020; 10():624493. PubMed ID: 33680947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis
    Zheng X; Gou Y; Jiang Z; Yang A; Yang Z; Qin S
    Front Oncol; 2021; 11():740557. PubMed ID: 34765550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLX3 repressed SNAI1-induced epithelial-mesenchymal transition by directly constraining STAT3 phosphorylation and functionally sensitized 5-FU chemotherapy in hepatocellular carcinoma.
    Wang C; Dou C; Wang Y; Liu Z; Roberts L; Zheng X
    Int J Biol Sci; 2019; 15(8):1696-1711. PubMed ID: 31360112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src/STAT3/NF-κB-Mediated Epithelial-Mesenchymal Transition and Metastasis.
    Weng YS; Chiang IT; Tsai JJ; Liu YC; Hsu FT
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):719-732. PubMed ID: 36245124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of 3,3'4,4',5-pentachlorobiphenyl-induced epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Song L; Guo L; Li Z
    Toxicol Appl Pharmacol; 2017 May; 322():75-88. PubMed ID: 28284859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-associated Fibroblasts induce epithelial-mesenchymal transition
    Jia C; Wang G; Wang T; Fu B; Zhang Y; Huang L; Deng Y; Chen G; Wu X; Chen J; Pan Y; Tai Y; Liang J; Li X; Hu K; Xie B; Li S; Yang Y; Chen G; Zhang Q; Liu W
    Int J Biol Sci; 2020; 16(14):2542-2558. PubMed ID: 32792856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
    Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
    Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
    Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3.
    Wang Y; Li N; Zheng Y; Wang A; Yu C; Song Z; Wang S; Sun Y; Zheng L; Wang G; Liu L; Yi J; Huang Y; Zhang M; Bao Y; Sun L
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
    Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
    Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RIPK4 Suppresses the Invasion and Metastasis of Hepatocellular Carcinoma by Inhibiting the Phosphorylation of STAT3.
    Li H; Luo D; Huttad L; Zhang M; Wang Y; Feng J; Ding Y; Han B
    Front Mol Biosci; 2021; 8():654766. PubMed ID: 34222329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.
    Attia YM; Tawfiq RA; Gibriel AA; Ali AA; Kassem DH; Hammam OA; Elmazar MM
    Biochem Pharmacol; 2021 Apr; 186():114497. PubMed ID: 33675775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
    Tu M; He L; You Y; Li J; Yao N; Qu C; Huang W; Xu L; Luo R; Hong J
    Cell Death Dis; 2020 Oct; 11(10):830. PubMed ID: 33024090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPRC5A exerts its tumor-suppressive effects in breast cancer cells by inhibiting EGFR and its downstream pathway.
    Yang L; Ma T; Zhang J
    Oncol Rep; 2016 Nov; 36(5):2983-2990. PubMed ID: 27599526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A.
    Mi L; Lei L; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J; Yin F
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.
    Zheng XB; Chen XB; Xu LL; Zhang M; Feng L; Yi PS; Tang JW; Xu MQ
    Cancer Sci; 2017 Mar; 108(3):338-346. PubMed ID: 28100026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.